ArticleJournal of autoimmunity2020

High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients.

Enrique Iglesias-Julián et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.